Erez Israeli
Tracked across 3 events · 36 articles · First seen May 28, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories Limited regarding potential securities fraud or other unlawful business practices. The investigation stems from Dr. Reddy's announcement on July 22, 2026 of its…
Impact: CEO of Dr. Reddy's, quoted explaining the earnings miss and semaglutide-related challenges; his statements are central to the investigation.
Aug 25, 2026 · 6 articles
Business
Impact: Erez Israeli, CEO of Abbott Laboratories, attended the closing bell ceremony, representing the company's leadership.
May 28, 2026 · 7 articles
Business
Impact: CEO; explained semaglutide issue and maintained FY27 outlook, but his earlier margin statements are under investigation.
Jul 09, 2026 · 23 articles
ERGEN INTELLIGENCE
Track Erez Israeli live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard